BIT's 7th Annual World Congress of Vaccine - 2015
★ Event Report

Following on the successful organizing of WCV-2014, we are pleased to announce the next WCV conference will be held during April 25-28, 2015 in Nanjing, China. With the theme of “New Horizon for Vaccine Innovation toward 2025”, we will once again offer professionals in the field of vaccine a multidisciplinary informative platform.

WCV-2015 contributes to provide a unique platform which will bring together thought leaders from pharmaceutical, biotech companies, consultants, regulatory authorities and academics, to present the latest research results, ideas, developments, applications and business prospects in Vaccine Research and Technologies, Vaccine Drugs, and Production, Vaccine Market Trend & Policy, etc.

In additional to the speeches in Scientific Program, this new event will bring participants resourceful activities, such as Mini-Symposia, Roundtable and Panel Discussion, Matchmaking and Partnering, Career Development, Field Trip and Tech-Tour, etc. We believe all these operations will provide participants with a more significant and fruitful experience in China.


China Local Time
Days to Go!
New Release

Early bird registration for speech opportunity is open.
The scientific program is released.
• Call for speakers, exhibitors and sponsors worldwide.
• Call for media partners and advertiser worldwide.
Register now to enjoy favorable discount.

Who's Attended
Past Year's Event
Scientific Group Leader, Institute of Marine Research
Vice President, MannKind Corp
Director, Astellas Pharma Inc
Head, NanoSight Ltd
Director& CEO, VIDO/InterVac
Adjunct Professor, Karolinska Institute
General Project Manager, Health Protection Agency
CEO, Vakzine Projekt Management
Vice President, GlaxoSmithKline Biologicals
Vice President, Asia Region, BIA Separations
Associate Investigator, National Health Research Institutes
Associate Professor, University of Copenhagen
Professor, Tieraerztliche Hochschule Hannover
Vice President, Chinese Society for Immunolgy
Professor, University of Lille2 and University of Artois
Professor, Norfolk State University
Professor, Queensland Institute of Medical Research
President/CEO, Synergy America, Inc
Professor, University of Rome La Sapienza
Chief Medical Officer, Research Triangle Park
Professor, Catholic University
Professor, D Cotugno Hospital
Vice President, Selecta Biosciences, Inc
Group Product Manager, Pfizer China
President, Antagen Biosciences, Inc
Director, GlaxoSmithKline Biologicals
Chief Scientific Officer, GeoVax, Inc
Senior Vice President Technovax, Inc
Senior Research Fellow, Astellas Pharma Inc
Director, Astellas Pharma Inc
Director, Sanofi-Pasteur
General Manager, Oxford-Emergent Tuberculosis Consortium Ltd
Associate Professor, Deakin University
Professor, University of Copenhagen
Professor, Center of Structural Biology and Bioinformatics
Senior Vice President, GlaxoSmithKline Biologicals
Vice President, Transgene S.A
Vice President, Sanofi-Pasteur
Global Head, Novartis Vaccines & Diagnostics
Director, Waters Corporation
Professor, National Yang-Ming University
Senior Scientist, BD Techologies
Professor, University of Ulm
Senior Director, Emergent BioSolutions
Vice President, Isconova
Senior Investigator, National Institute of Health
Director, MedImmune
CEO, TechnoVax, Inc
CEO, AXIO France
Director, Global Medical Affairs
Hosting Organizations
Operating Organizations

Economic Information Department, China Council for the Promotion of International Trade

Nanjing Economic and Information Commission

The Bureau of the Nanjing Food and Drug Administration

Nanjing Municipal Investment Promotion Commission

Nanjing Municipal Health Bureau

China Council for the Promotion of International Trade, Nanjing Sub-Council

Zhen-Ao Group

BIT Congress Inc.
Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

Upcoming Conferences

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.